Health Coaching Telemedicine Program for Lung Transplant Candidates With End-stage Lung Disease.
Launched by SHEBA MEDICAL CENTER · May 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a health coaching program delivered through telemedicine for patients with end-stage lung disease who are waiting for a lung transplant. The goal is to see if this program can help improve patients' physical health, emotional wellbeing, and overall quality of life while they wait for surgery. By encouraging healthy habits like better nutrition, increased physical activity, and quitting smoking, researchers hope that patients will be better prepared for their transplant, experience fewer complications, and have better outcomes after the surgery.
To be eligible for this study, participants should be between the ages of 65 and 74, have been assessed as suitable for lung transplantation due to their end-stage lung disease, and be willing to watch online instructional videos. Those who are unable to provide consent, are uncooperative, or cannot connect to video conferencing will not be included. If you decide to participate, you can expect to receive support and guidance from health coaches who will help you manage your condition and prepare for the transplant process. This trial could be an important step in finding new ways to support patients during this critical time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with end stage lung disease assessed suitable for lung transplantation.
- • Able and willing to watch online instructional videos.
- Exclusion Criteria:
- • Unwilling or unable to provide consent
- • Uncooperative or combative
- • Unable to use / connect to video conferencing
About Sheba Medical Center
Sheba Medical Center, located in Israel, is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, Sheba Medical Center leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and developing novel therapeutic interventions. The center's collaborative environment fosters partnerships with global research organizations, enhancing its ability to contribute to the scientific community and drive medical advancements across various fields. With a strong focus on patient safety and ethical standards, Sheba Medical Center is dedicated to translating research findings into practical applications that benefit patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ramat Gan, , Israel
Ramat Gan, , Israel
Patients applied
Trial Officials
Rani Polak, PhD
Principal Investigator
Sheba Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported